Patrick Schlegel
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 16
- Immunology top 5%
- Immune Cell Function and Interaction 16
- T-cell and B-cell Immunology 6
- Oncology top 5%
- CAR-T cell therapy research 20
- Transplantation top 10%
-
- Virus-based gene therapy research 3
-
- Neuroblastoma Research and Treatments 6
-
- Nanowire Synthesis and Applications 5
-
- Acute Lymphoblastic Leukemia research 4
Patrick Schlegel
44 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 69
- Hematology 329
- Immunology 498
- Oncology 529
- Transplantation 21
- Genetics 62
Countries citing papers authored by Patrick Schlegel
This map shows the geographic impact of Patrick Schlegel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Schlegel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Schlegel more than expected).
Fields of papers citing papers by Patrick Schlegel
This network shows the impact of papers produced by Patrick Schlegel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Schlegel. The network helps show where Patrick Schlegel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Patrick Schlegel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 12 | |
| 2 | 2021 | 37 | |
| 3 | 2020 | 4 | |
| 4 | 2020 | 2 | |
| 5 | 2020 | 32 | |
| 6 | 2019 | 4 | |
| 7 | 2019 | 3 | |
| 8 | 2019 | 5 | |
| 9 | 2018 | 8 | |
| 10 | 2018 | 8 | |
| 11 | 2018 | 64 | |
| 12 | 2017 | 3 | |
| 13 | 2017 | 40 | |
| 14 | 2017 | 34 | |
| 15 | 2016 | 17 | |
| 16 | 2013 | 14 | |
| 17 | 2013 | 187 | |
| 18 | 2012 | 42 | |
| 19 | 2011 | 15 | |
| 20 | 1998 | 15 |
About Patrick Schlegel
Patrick Schlegel is a scholar working on Hematology, Immunology and Oncology, having authored 44 papers that have together received 1.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (20 papers), Immune Cell Function and Interaction (16 papers), Hematopoietic Stem Cell Transplantation (16 papers), Neuroblastoma Research and Treatments (6 papers), T-cell and B-cell Immunology (6 papers), Nanowire Synthesis and Applications (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Hematology (329 citations), Immunology (498 citations) and Oncology (529 citations). Patrick Schlegel has collaborated with scholars based in Germany, Australia and Austria. Frequent co-authors include Peter Lang, Rupert Handgretinger, Tobias Feuchtinger, Martin Ebinger, Michaela Döring, Michael Schumm, Christian Seitz, Judith Feucht, Leticia Quintanilla-Martı́nez and Heiko‐Manuel Teltschik. Their work appears in journals such as Blood, British Journal of Haematology, Bone Marrow Transplantation, Frontiers in Immunology and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.